Neuroblastoma

Neuroblastoma is cancer that arises in immature nerve cells and affects mostly infants and children.
What is Neuroblastoma?

Neuroblastoma is a rare childhood cancer that develops from immature nerve cells called neuroblasts. “Neuro” means nerve, while “blast” refers to immature cells and “oma” means a tumor or group of cells. Neuroblastoma usually develops in infants under the age of five years and very rarely in older children, teenagers and adults.

Read More

Overview

Feature Articles

Latest Neuroblastoma News and Research

New project seeks to understand the origin and role of ecDNA in cancer development

New project seeks to understand the origin and role of ecDNA in cancer development

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Removing copper from blood can destroy deadliest cancers that are resistant to immunotherapy

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Researchers create new tool to identify cancer-causing mutations lurking in 98% of the genome

Researchers create new tool to identify cancer-causing mutations lurking in 98% of the genome

Smart MRI scan used for heart disease can help assess aggressive cancers in children

Smart MRI scan used for heart disease can help assess aggressive cancers in children

Interactive cloud-based data portal provides access to treasure trove of pediatric solid tumor data

Interactive cloud-based data portal provides access to treasure trove of pediatric solid tumor data

Novel radioisotope therapy could provide favorable prognosis in neuroblastoma patients

Novel radioisotope therapy could provide favorable prognosis in neuroblastoma patients

Study analyzes cancer diagnosis in children with birth defects

Study analyzes cancer diagnosis in children with birth defects

New high-throughput approach yields libraries of probes for immunological assays

New high-throughput approach yields libraries of probes for immunological assays

Scientists discover anti-cancer compound in the humble willow

Scientists discover anti-cancer compound in the humble willow

FDA approves immune-modulating therapy for treatment of multiple sclerosis

FDA approves immune-modulating therapy for treatment of multiple sclerosis

Despite failures, chemotherapy still promising against fatal pediatric brain cancer

Despite failures, chemotherapy still promising against fatal pediatric brain cancer

Advancing CAR T-cell therapy for treatment of solid tumors

Advancing CAR T-cell therapy for treatment of solid tumors

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

Novel computer algorithm identifies promising new treatment for neuroblastoma

Novel computer algorithm identifies promising new treatment for neuroblastoma

Extrachromosomal circular DNA can contribute to cancer development in children

Extrachromosomal circular DNA can contribute to cancer development in children

Study sheds light on the factors at play in neuroblastoma metastasis

Study sheds light on the factors at play in neuroblastoma metastasis